Expert panel discussion: latest treatment regimens, novel therapies and advances against NSCLC
Published this week as part of ecancer’s [...]
2020: a record-breaking year for VHIO’s Research Unit for Molecular Cancer Therapy (UITM) – “la Caixa” Foundation
Throughout 2020 and during the COVID-19 pandemic [...]
A new radiomic model based on artificial intelligence will help to predict the response to immunotherapy in cancer patients
Researchers from the VHIO, promoted by the [...]
World Cancer Day 2021: saluting the strength of the cancer community through the COVID-19 pandemic
Thursday, February 04 2021, not only celebrates [...]
The passing of a true giant and trailblazer in oncology: Prof. Gordon McVie 1945-2021
Officially announced yesterday by ecancer, Prof. Gordon [...]
Not to be missed: ESMO’s virtual and expert Live Roundtable on COVID-19 vaccination in cancer patients, this Friday 22 January
Delivering on the European Society for Medical [...]
VHIO to incorporate Guardant Health’s breakthrough liquid biopsy technology in 2021
During 2021, the Vall d’Hebron Institute of [...]
A step forward in the validation of reliable preclinical models for cancer research
*Source: EurOPDX Consortium Barcelona, January 8, [...]
Seeking out predictive biomarkers for a longer-term response to immunotherapy against NSCLC
While the rapidly emerging arsenal of immune-based [...]
The promise of KEYNOTE-177: Nature Reviews Clinical Oncology’s Research Highlight with invited comment from Josep Tabernero
As a leading cause of cancer death [...]